Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
ImmuPharma ( (GB:IMM) ) has provided an update.
ImmuPharma PLC has announced the exercise of 2,500,000 warrants over New Ordinary Shares, raising £125,000. The new shares, representing 0.50% of the company’s enlarged issued share capital, will be admitted to trading on the AIM market of the London Stock Exchange, impacting the company’s total issued share capital, which will consist of 502,223,932 Ordinary Shares.
More about ImmuPharma
ImmuPharma PLC is a specialty biopharmaceutical company focused on discovering and developing peptide-based therapeutics. The company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives.
Average Trading Volume: 6,683,876
Technical Sentiment Signal: Buy
Current Market Cap: £40.28M
Learn more about IMM stock on TipRanks’ Stock Analysis page.